Unable to display view head.php file not found.
 
 

James A. Reiffel, MD - Novel Oral Anticoagulants - Figure 32

Baseline data

The Figure shows the baseline population demographics for ROCKET AF.[97] It can be seen that the population was quite similar in most respects to the enrollees in RE-LY, with a good distribution across the spectrum of renal function (shown at the bottom of the Table).

 Reiffel JA. Am J Med 2013; 126: 00-00.

Complete references for all slides

References

[97] Patel MR, Mahaffey KW, Garg J, et al; the ROCKET AF Steering Committee, for the ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.

Unable to display view foot.php file not found.